Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Key trial updates from SABCS 2020

Komal Jhaveri • 11 Dec 2020
SABCS 2020
Breast Cancer
RxPONDER

Komal Jhaveri, MD, FACP, Memorial Sloan Kettering Cancer Center, New York, NY, explores practice changing data presented at this years annual San Antonio Breast Cancer Symposium (SABCS), these include the results of the RxPONDER trial which evaluated whether chemotherapy could be spared in women with node-positive early stage breast cancer based on OncoType Dx ® score. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Komal Jhaveri

1:48
Navigating treatment decisions for patients with HR+/ HER- mBC
Komal Jhaveri • 11 May 2023
2:06
Exploring novel therapeutic approaches in HR+/ HER2- mBC
Komal Jhaveri • 11 May 2023
3:15
Investigating targeted therapy combinations in metastatic HR+ breast cancer
Komal Jhaveri • 11 May 2023
1:18
Breast cancer trends in 2021 and beyond
Komal Jhaveri • 11 Dec 2020

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals